ClinicalTrials.Veeva

Menu

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

N

Nanjing Medical University

Status

Enrolling

Conditions

Keloid

Treatments

Other: hyperthermia

Study type

Interventional

Funder types

Other

Identifiers

NCT06431360
KY20240514-02

Details and patient eligibility

About

Keloid patients were randomized into the experimental and control groups. Experimental group: Strontium-90 (Sr-90) brachytherapy followed by hyperthermia. Control group: Sr-90 brachytherapy alone .

Full description

Sr-90 brachytherapy: 6-7 Gy each time, twice a week for 3 weeks; Hyperthermia: using a heater, 44℃ for 15 min

Enrollment

80 estimated patients

Sex

All

Ages

16 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient was clinically diagnosed with keloid, and the keloid area was clean without rupture and exudation;
  • Body surface keloid thickness: 2~5mm, diameter ≥10mm.

Exclusion criteria

  • Women who plan to become pregnant within 3 months or are pregnant or breastfeeding;
  • Patients with cicatricial constitution;
  • Abnormal coagulation function;
  • Patients who have received an adequate dose or course of radiation therapy;
  • People with previous immune system diseases, diabetes and other metabolic diseases.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Experimental group
Experimental group
Description:
Sr-90 brachytherapy followed by hyperthermia.
Treatment:
Other: hyperthermia
Control group
No Intervention group
Description:
Sr-90 brachytherapy alone.

Trial contacts and locations

2

Loading...

Central trial contact

Liang Shi; Feng Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems